Simian immunodeficiency virus-infected macaques treated with highly active antiretroviral therapy have reduced central nervous system viral replication and inflammation but persistence of viral DNA - Wikidata - wikimedia - TriplyDB

Simian immunodeficiency virus-infected macaques treated with highly active antiretroviral therapy have reduced central nervous system viral replication and inflammation but persistence of viral DNA

Simian immunodeficiency virus-infected macaques treated with highly active antiretroviral therapy have reduced central nervous system viral replication and inflammation but persistence of viral DNA

http://www.wikidata.org/entity/Q33893665

about

Eradication of HIV from the brain: reasons for pause HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment Animal Models for HIV Cure Research The macrophage: a therapeutic target in HIV-1 infection Unraveling the pathogenesis of HIV peripheral neuropathy: insights from a simian immunodeficiency virus macaque model Considerations in the development of nonhuman primate models of combination antiretroviral therapy for studies of AIDS virus suppression, residual virus, and curative strategies Redefining the viral reservoirs that prevent HIV-1 eradication Rational development of radiopharmaceuticals for HIV-1 Adipose Tissue Is a Neglected Viral Reservoir and an Inflammatory Site during Chronic HIV and SIV Infection Persistence of viral reservoirs in multiple tissues after antiretroviral therapy suppression in a macaque RT-SHIV model Targeting the Brain Reservoirs: Toward an HIV Cure Using animal models to overcome temporal, spatial and combinatorial challenges in HIV persistence research Effects of treatment with suppressive combination antiretroviral drug therapy and the histone deacetylase inhibitor suberoylanilide hydroxamic acid; (SAHA) on SIV-infected Chinese rhesus macaques Eradication therapies for HIV Infection: time to begin again.Loss of a tyrosine-dependent trafficking motif in the simian immunodeficiency virus envelope cytoplasmic tail spares mucosal CD4 cells but does not prevent disease progression.The National NeuroAIDS Tissue Consortium brain gene array: two types of HIV-associated neurocognitive impairment.Is the central nervous system a reservoir of HIV-1?Combination fluconazole/paroxetine treatment is neuroprotective despite ongoing neuroinflammation and viral replication in an SIV model of HIV neurological disease.Neuroinflammation and virus replication in the spinal cord of simian immunodeficiency virus-infected macaques.Giant cell encephalitis and microglial infection with mucosally transmitted simian-human immunodeficiency virus SHIVSF162P3N in rhesus macaques Replication-competent simian immunodeficiency virus (SIV) Gag escape mutations archived in latent reservoirs during antiretroviral treatment of SIV-infected macaques.Eradicating HIV-1 infection: seeking to clear a persistent pathogen.Detection of Simian Immunodeficiency Virus in Semen, Urethra, and Male Reproductive Organs during Efficient Highly Active Antiretroviral Therapy Quinolinic acid/tryptophan ratios predict neurological disease in SIV-infected macaques and remain elevated in the brain under cART.Of mice and monkeys: can animal models be utilized to study neurological consequences of pediatric HIV-1 infection?Persistent Peripheral Nervous System Damage in Simian Immunodeficiency Virus-Infected Macaques Receiving Antiretroviral Therapy HIV-1 Nef in macrophage-mediated disease pathogenesis.Cell-cell contact viral transfer contributes to HIV infection and persistence in astrocytes Overcoming pharmacologic sanctuaries.A plasma microRNA signature of acute lentiviral infection: biomarkers of central nervous system disease.Antiretroviral monocyte efficacy score linked to cognitive impairment in HIV.Early detection of simian immunodeficiency virus in the central nervous system following oral administration to rhesus macaques.Effect of morphine and SIV on dendritic cell trafficking into the central nervous system of rhesus macaques.Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system A simian immunodeficiency virus macaque model of highly active antiretroviral treatment: viral latency in the periphery and the central nervous system.HIV and neurocognitive dysfunction.Targeting HIV latency: resting memory T cells, hematopoietic progenitor cells and future directions.Neuropathogenesis of HIV: from initial neuroinvasion to HIV-associated neurocognitive disorder (HAND)CNS reservoirs for HIV: implications for eradication.Fate of microglia during HIV-1 infection: From activation to senescence?

P2860

Q24612874-32572D2C-674B-4E71-97CA-D494F228BEA8 Q26766448-A18B6677-9A06-4D8B-8077-6D303FE93FD2 Q26767476-CEECA3BC-6153-4459-BC7E-593237EBA93D Q26823236-98C086B7-50C0-48B7-B05F-EC97593F0991 Q26825231-D97C3284-218D-4FD0-BBE8-FDEF74125697 Q26825814-788EB858-A50E-4C56-ABB7-FC8F0E7EA2D4 Q26827255-42C16DA2-9AA8-4C7C-872F-4D18B605D90E Q27022025-F4CC892D-2947-4254-A086-5F58D2C84FC2 Q27317216-350D4A20-B1A4-402A-8017-71035B817E65 Q27335485-B24FF1BF-4481-49CA-91AC-36F62DF79244 Q28075694-64FDDB8C-201B-48EE-B376-D20605A53C7C Q28077662-3274B6D4-814B-4A7D-8714-773A818B8F31 Q28540858-8963F7D2-EE67-418C-AC52-F91C1AAEB192 Q30399588-B3C57C7F-21A4-4180-B9CF-A0BA065BE75D Q30532862-4779149E-151D-499D-99F9-68BE6FAA4F11 Q31104394-4F0145BC-84E9-43B4-965F-4D2A21CC2C4E Q34434339-F6BDAE72-8909-4671-A6C0-973BDC2C9626 Q34714277-FD3FE1C7-1384-4A11-843D-88860ED571A0 Q34734802-3C84401C-6C44-4A04-899C-BC4365F7A75B Q35110503-3F5102E8-013E-40A9-9BA3-05B03EF9D97E Q35192975-5F9D7A17-928E-42AC-9989-C4BA1E5B554C Q35252186-C93DC393-9E69-4E7E-9C3C-0FB6BC06BEB0 Q35641179-E8F5EA3D-F35C-4AF3-99CF-59E2369D80C8 Q35883306-8D2C7DAC-90B3-46AF-BD3F-4D90BCA675C5 Q35984276-3327B78D-75FA-4724-B21F-83DE7408DBD5 Q36167247-B98F135C-967D-4610-B1DA-B0249F6EB7F6 Q36531107-A10ABCA1-761C-4051-B478-F64040DFC9A7 Q36883462-7A893E12-7CF7-45C0-96B7-D902443766D8 Q36915933-D0807E4F-2548-429A-A64F-712F1D66D32C Q36989920-5D0F4B5A-6369-4C36-9E3D-1B03760A9CCF Q37024994-AD71C7D0-DE3E-422F-8895-390223E16F97 Q37094265-EA5076DA-5577-467D-98AA-0DD111D34DF3 Q37585706-4DEF436A-D3A2-4645-9E24-F24D55080DB7 Q37592018-F90D1CC2-D72A-4FFB-AD26-232320D5B66B Q37829628-8F5A118F-CE0D-419E-A86B-D4261A636231 Q38122104-E5057FD7-BFFC-4F8E-82D0-54536617E1EA Q38246141-A1FCEF03-9B00-4BC7-9729-4B9AB1320E7E Q38258410-83AAD8EE-4D02-4738-98E8-DB462A68B5C4 Q38597765-79F6B90E-C3F0-4C7F-8D42-BDDF98FEDA2B Q38790617-17FFB19B-4087-4F97-86D7-63ECD5537760

P2860

Simian immunodeficiency virus-infected macaques treated with highly active antiretroviral therapy have reduced central nervous system viral replication and inflammation but persistence of viral DNA

http://www.wikidata.org/entity/Q33893665

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Simian immunodeficiency virus- ...... n but persistence of viral DNA

@ast

Simian immunodeficiency virus- ...... n but persistence of viral DNA

@en

type

label

Simian immunodeficiency virus- ...... n but persistence of viral DNA

@ast

Simian immunodeficiency virus- ...... n but persistence of viral DNA

@en

prefLabel

Simian immunodeficiency virus- ...... n but persistence of viral DNA

@ast

Simian immunodeficiency virus- ...... n but persistence of viral DNA

@en

P1433

Q33893665-F19C5375-8541-4497-BB3C-BAF75ECF8BD5

P1476

Q33893665-5116B2E3-8F42-4996-8ED5-978D9C0FDDB0

P2093

Q33893665-041A5913-2CFE-4FB0-93FF-9E05E3BF0263

Q33893665-170E15B7-189F-4696-AF90-C394FE545F14

Q33893665-22762C89-6D3D-413E-A922-2AED1CAEB24D

Q33893665-309081F6-ABE1-47FD-A1CD-8F16717F3031

Q33893665-331C8AE3-3A30-42A9-BC13-F292CB1659F2

Q33893665-37286EE7-2D9D-4DC0-ABC7-57D86E7E4E42

Q33893665-6C78064A-B91E-4112-912D-2588B13ABFFC

Q33893665-6E6547EE-39D3-469A-94D5-1DB2F3611FEE

Q33893665-8AD54024-B4B0-4D02-8622-E05DD4770FDB

Q33893665-A0EA523D-2EC8-4CFD-91C4-D30C1A4932F2

P2860

Q33893665-00D5B88F-9C18-4D19-85DE-0E861FE96855

Q33893665-042A949B-C66D-41DC-A8EE-83C8FBD9CD4A

Q33893665-0CD432D6-E0F0-479D-8455-6271A644AA88

Q33893665-0D2267D8-6920-4F36-BC6B-2D5E8FB33110

Q33893665-10E87CB7-D580-49D0-932B-3762DA09D965

Q33893665-113320FB-D2F3-4942-A290-752D8C3BBD88

Q33893665-152BAEE6-69AB-4FD9-8CF7-E4657BE52793

Q33893665-20C46B10-DF7D-4573-838E-74503FD33868

Q33893665-21BA6167-AB3F-4AF4-810B-C50F13EF2126

Q33893665-222B53D0-FD67-4E23-98AD-5B717B6F25EE

P304

Q33893665-B8743F64-3B33-495B-A3B3-943C7E53AC33

P31

Q33893665-51149660-3B51-4A0C-A405-43D78745A0A7

P356

Q33893665-DBE1BF7F-FD35-4A89-9937-361520DDF241

P407

Q33893665-A76EBF09-BF63-4698-B7FE-3C60F2FFD782

P433

Q33893665-D56C67C0-CED3-449A-830F-8FF20B8DFD63

P478

Q33893665-3B64EFAE-DE0D-453B-BC4A-F52F5A52AF1C

P577

Q33893665-81F99F75-FF80-476B-A8F2-8A7662E8C80C

P5875

Q33893665-6529431E-638C-4498-A44E-712C9E6D2CA6

P698

Q33893665-DCC4D804-9A4C-4CCF-AA2F-EE402FC434A8

P921

Q33893665-025C28D2-20BB-4882-A29D-756E73E3F273

Q33893665-89ABC240-1D13-4C0E-84AC-F580A2EEA630

Q33893665-FAD522DD-B37C-419E-903E-F2331457AA25

P932

Q33893665-339B3D23-7B52-48D2-800F-3E78CD47713E

P356

P1433

The Journal of Infectious Diseases

P1476

Simian immunodeficiency virus- ...... n but persistence of viral DNA

@en

P2093

Angela K Brice

http://www.w3.org/2001/XMLSchema#string

Christopher Bartizal

http://www.w3.org/2001/XMLSchema#string

David R Graham

http://www.w3.org/2001/XMLSchema#string

Janice E Clements

http://www.w3.org/2001/XMLSchema#string

John Varrone

http://www.w3.org/2001/XMLSchema#string

Joseph L Mankowski

http://www.w3.org/2001/XMLSchema#string

Kathleen M Kelly

http://www.w3.org/2001/XMLSchema#string

Lucio Gama

http://www.w3.org/2001/XMLSchema#string

M Christine Zink

http://www.w3.org/2001/XMLSchema#string

Ming Li

http://www.w3.org/2001/XMLSchema#string

P2860

Immunopathogenesis and immunotherapy in AIDS virus infections

Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases

Quantitative real-time RT-PCR data analysis: current concepts and the novel "gene expression's CT difference" formula

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

Viral dynamics in human immunodeficiency virus type 1 infection

Decay characteristics of HIV-1-infected compartments during combination therapy

CD4+ count-guided interruption of antiretroviral treatment

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

Potential impact of early antiretroviral therapy on transmission.

Tenofovir-related Fanconi syndrome with nephrogenic diabetes insipidus in a patient with acquired immunodeficiency syndrome: the role of lopinavir-ritonavir-didanosine.

P304

161-170

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/653213

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

202

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44625126

http://www.w3.org/2001/XMLSchema#string

P698

20497048

http://www.w3.org/2001/XMLSchema#string

P921

Simian immunodeficiency virus

viral persistence

antiretroviral drug

P932

2880623

http://www.w3.org/2001/XMLSchema#string